Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
IN RE: Insulin Pricing Litigation
-
August 04, 2023
JPML Centralizes Insulin Price-Fixing Suits In New Jersey
The Judicial Panel of Multidistrict Litigation has sent five state cases against insulin manufacturers such as Eli Lilly and pharmacy benefit managers including CVS to the District of New Jersey, ruling the district will allow for efficient pretrial proceedings.
-
July 27, 2023
5 AGs Urge JPML To Group Gov't Insulin Pricing Suits
Counsel for five state attorney generals urged the Judicial Panel on Multidistrict Litigation at a hearing in San Francisco on Thursday to group government cases claiming that pharma giants including Eli Lilly and pharmacy benefit managers such as CVS conspired to hike insulin prices, citing the need for "cooperation and efficiency."
-
July 25, 2023
On Deck In JPML: Insulin Pricing, Bard Catheters, Southwest
This week in San Francisco, the Judicial Panel on Multidistrict Litigation will consider whether to centralize three clusters of litigation, including claims against insulin makers that they've worked over two decades to raise the critical drug's price through the roof.